Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $2.4 million.

  • Cytokinetics' Depreciation & Amortization (CF) fell 6238.36% to $2.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $9.5 million, marking a year-over-year decrease of 1985.37%. This contributed to the annual value of $9.5 million for FY2024, which is 1985.37% down from last year.
  • Per Cytokinetics' latest filing, its Depreciation & Amortization (CF) stood at $2.4 million for Q4 2024, which was down 6238.36% from $2.4 million recorded in Q3 2024.
  • In the past 5 years, Cytokinetics' Depreciation & Amortization (CF) ranged from a high of $6.3 million in Q4 2023 and a low of $408000.0 during Q1 2020
  • For the 5-year period, Cytokinetics' Depreciation & Amortization (CF) averaged around $1.6 million, with its median value being $1.4 million (2022).
  • As far as peak fluctuations go, Cytokinetics' Depreciation & Amortization (CF) soared by 28208.69% in 2023, and later tumbled by 6238.36% in 2024.
  • Quarter analysis of 5 years shows Cytokinetics' Depreciation & Amortization (CF) stood at $471000.0 in 2020, then surged by 55.84% to $734000.0 in 2021, then surged by 125.89% to $1.7 million in 2022, then skyrocketed by 282.09% to $6.3 million in 2023, then tumbled by 62.38% to $2.4 million in 2024.
  • Its Depreciation & Amortization (CF) was $2.4 million in Q4 2024, compared to $2.4 million in Q3 2024 and $2.4 million in Q2 2024.